Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?

Documenti analoghi

• Place of mTOR inhibitors in management of BKV infection after kidney transplantation
  di: Jouve, Thomas, et al.
  Pubblicazione: (2016)
• Costimulation Blockade in Kidney Transplantation: An Update
  di: Malvezzi, Paolo, et al.
  Pubblicazione: (2016)
• Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
  di: Malvezzi, Paolo, et al.
  Pubblicazione: (2015)
• Transplantation of Marginal Organs: Immunological Aspects and Therapeutic Perspectives in Kidney Transplantation
  di: Johan Noble, et al.
  Pubblicazione: (2020-01-01)
• Corrigendum to Commentary “Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?” [EBioMedicine DOI: https://doi.org/10.1016/j.ebiom.2018.07.032]
  Pubblicazione: (2018)